OpenAI & Retro's Stem Cell Breakthrough, AI-Guided Surgery Milestone, and More! - Life AI Weekly #34

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in Healthcare and Life Sciences AI. This week, we explore a range of exciting developments, including OpenAI and Retro Biosciences teaming up to enhance stem cell reprogramming, and Absci partnering with Oracle and AMD to push the boundaries of AI in drug discovery. These collaborations highlight the growing trend of leveraging AI to accelerate breakthroughs in medical research and treatment.

In the realm of healthcare technology, Levita Magnetics has conducted the first AI-guided gallbladder surgery, marking a significant milestone in surgical innovation. Meanwhile, Renalytix and Tempus have joined forces to advance AI kidney diagnostics, aiming to improve patient outcomes through cutting-edge technology. Stay tuned as we continue to bring you the latest updates and insights from the intersection of AI and healthcare.

Hello Patient has raised $22.5 million to enhance its AI-driven patient communication technology, while Teton.ai secured $20 million to improve senior care with predictive AI. These investments highlight the growing focus on AI solutions in healthcare to automate interactions and enhance care outcomes.

PhaseV will present its AI/ML solutions at upcoming biopharma conferences, aiming to enhance clinical trial efficiency. Meanwhile, OpenAI and Retro Biosciences have achieved a 50-fold increase in stem cell reprogramming efficiency, potentially advancing regenerative medicine.

Colgate-Palmolive is partnering with biomaterials company Erthos to develop an AI tool named Zya, aimed at enhancing sustainable biopolymer packaging materials, with a commercial launch planned for early 2026.
Gyala Therapeutics has announced promising preclinical results for its CAR-T therapy GYA01, targeting the CD84 protein, showing potential for treating leukemia.

Levita Magnetics has achieved a milestone by conducting the first AI-guided gallbladder surgery using its MARS platform at Clínica Las Condes in Santiago, Chile. Meanwhile, Kanematsu Corporation and Enchanted Tools have signed an agreement to introduce the humanoid AI robot Mirokaï in Japan, enhancing capabilities like facial recognition and interactive dialogue.